Overview

Low Dose Bismuth Versus Lactobacillus Reuteri for H. Pylori Eradication

Status:
Terminated
Trial end date:
2018-12-23
Target enrollment:
Participant gender:
Summary
This study investigates the efficacy of a b.i.d. quadruple therapy containing Pylera® or L. reuteri for H. pylori infection.
Phase:
N/A
Details
Lead Sponsor:
Università degli Studi di Sassari
Treatments:
Bismuth
Bismuth tripotassium dicitrate
Metronidazole
Pantoprazole
Tetracycline